Patents by Inventor Aijie QI

Aijie QI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250041195
    Abstract: The present application provides a collagen type III composition prepared from a fibroblast extracellular matrix. The collagen type III is ultimately prepared by further purification, detection, and isolation based on the extracellular matrix components in a conditioned culture solution for fibroblasts, which are the most important cells in the human skin dermis, and can be combined with hyaluronic acid to form a composition formulation for use by people who want to remove and fill wrinkles on face and neck. The method is a production technique of the collagen type III composition from the fibroblast extracellular matrix, which belongs to a transplantation technology. More specifically, the human collagen is prepared from the cell culture supernatant by in vitro culturing the skin donated by volunteers for fibroblasts. The detection results of HIV, HBV, HCV, and syphilis infection markers are all non-reactive, mycoplasma is negative, and bacterial detection is negative.
    Type: Application
    Filed: October 23, 2024
    Publication date: February 6, 2025
    Applicant: SINO UNITED (BEIJING) BIOMEDICAL TECHNOLOGY CO., LTD.
    Inventors: Aijie QI, Shaobo LI, Qingxuan CHEN, Subi WEI
  • Patent number: 11801265
    Abstract: The present disclosure relates to a method for preparing NK cells and an application thereof in treatment of a cancer. The present disclosure provides a pharmaceutical composition prepared from NK cells and a monoclonal antibody of CD105, which can be used for the treatment of colorectal cancer and has a good application prospect.
    Type: Grant
    Filed: January 24, 2022
    Date of Patent: October 31, 2023
    Assignee: SINO UNITED (BEIJING) BIOMEDICAL TECHNOLOGY CO., LTD.
    Inventors: Aijie Qi, Shaobo Li, Ailei Qi
  • Publication number: 20220233591
    Abstract: The present disclosure relates to a method for preparing NK cells and an application thereof in treatment of a cancer. The present disclosure provides a pharmaceutical composition prepared from NK cells and a monoclonal antibody of CD105, which can be used for the treatment of colorectal cancer and has a good application prospect.
    Type: Application
    Filed: January 24, 2022
    Publication date: July 28, 2022
    Inventors: Aijie QI, Shaobo LI, Ailei QI